NCT00777517
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- Pfizer Investigational Site Singapore
Clinical trial condition
Lipid Metabolism Disorders
Explore clinical trials studying Lipid Metabolism Disorders. Study availability and eligibility vary by location and protocol.
3,312 public trials
328 recruiting studies
Lipid Metabolism Disorders trial results
NCT00645151
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Pfizer Investigational Site Belo Horizonte, Minas Gerais, Brazil
- Pfizer Investigational Site Curitiba, Paraná, Brazil
- Pfizer Investigational Site Porto Alegre, Rio Grande do Sul, Brazil
- Pfizer Investigational Site Porto Alegre, Rio Grande do Sul, Brazil
NCT00136942
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site Binningen, Basel-Landschaft, Switzerland
- Pfizer Investigational Site Liestal, Basel-Landschaft, Switzerland
- Pfizer Investigational Site Basel, Canton of Basel-City, Switzerland
- Pfizer Investigational Site Langenthal, Canton of Bern, Switzerland
NCT00644670
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Pfizer Investigational Site Antwerp, Belgium
- Pfizer Investigational Site Brasschaat, Belgium
- Pfizer Investigational Site Brussels, Belgium
- Pfizer Investigational Site Edegem, Belgium
NCT00442845
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Brain Diseases, +23 more
- Locations
-
- Pfizer Investigational Site Mississauga, Ontario, Cameroon
- Pfizer Investigational Site Calgary, Alberta, Canada
- Pfizer Investigational Site Edmonton, Alberta, Canada
- Pfizer Investigational Site Medicine Hat, Alberta, Canada
Completed
HDDO-1756 Bio Equivalence Study
NCT04755894
- Conditions
- Dyslipidemias, Hyperlipidemias, Lipid Metabolism Disorders, +2 more
- Locations
-
- Hyundai Pharm Seoul, South Korea
NCT00412113
- Conditions
- Cardiovascular Diseases, Dyslipidemia, Dyslipidemias, +5 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Mesa, Arizona, United States
NCT04587206
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hypertension, +5 more
- Locations
-
- H Plus Yangji Hospital Seoul, Gwanak-gu, South Korea
NCT03407313
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, Cutis Laxa, +10 more
- Locations
-
- Aesthetx Campbell, California, United States
- Steve Yoelin, MD Medical Associates, Inc. Newport Beach, California, United States
- Roseville Facial Plastic Surgery Roseville, California, United States
- Miami Dermatology & Laser Institute Miami, Florida, United States
NCT02772640
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Behavior, +16 more
- Locations
-
- Cardiology Department, Dr. A. Jurasz University Hospital Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland